Cargando…
1845. Oritavancin Compared to the Standard-of-Care for the Treatment of Gram-positive Blood Stream Infections
BACKGROUND: Data is limited comparing oritavancin (ORT) to the standard-of-care (SOC) for the treatment gram-positive blood stream infections (BSI). METHODS: This was a retrospective study of all patients in the Veteran’s Affairs Health Care System treated with at least 1 dose of oritavancin or at l...
Autores principales: | Moenster, Ryan P, Wallace-Lacey, Ashleigh, Lorenz, Michael, Skouby, Danielle, Fong, Rebecca, Abdulbasir, Anosha, Abner, Hartley, Alberts, Justin, Doty, Johnathan, Tiefenauer, Seth, Western, Hannah, Linneman, Travis W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753036/ http://dx.doi.org/10.1093/ofid/ofac492.1474 |
Ejemplares similares
-
Oritavancin vs Standard of Care for Treatment of Nonendovascular Gram-Positive Bloodstream Infections
por: Moenster, Ryan P, et al.
Publicado: (2023) -
1553. Efficacy and Safety of Dalbavancin and Oritavancin in the Treatment of Gram-Positive Infections
por: Brown, Vanessa, et al.
Publicado: (2020) -
Real-World Evidence for Oritavancin Use in Gram-Positive Infections
Publicado: (2020) -
Oritavancin: A New Lipoglycopeptide Antibiotic in the Treatment of Gram-Positive Infections
por: Brade, Karrine D., et al.
Publicado: (2016) -
Real-World Experience with Oritavancin Therapy in Invasive Gram-Positive Infections
por: Stewart, Cassie L., et al.
Publicado: (2017)